Globus Medical price target raised to $87 from $78 at BTIG
BTIG raised the firm’s price target on Globus Medical (GMED) to $87 from $78 and keeps a Buy rating on the shares after its Q3 earnings ...
BTIG Sticks to Their Buy Rating for Masimo (MASI)
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...
Sector Winners and Losers From a New Administration
BTIG director of policy research Isaac Boltansky outlined the sectors that could benefit from Trump's election victory on ...
Fintel on MSN8h
BTIG Downgrades Tactile Systems Technology (TCMD)
Fintel reports that on November 5, 2024, BTIG downgraded their outlook for Tactile Systems Technology (NasdaqGM:TCMD) from Buy to Neutral. Analyst Price Forecast Suggests 59.79% Upside As of October ...